132 related articles for article (PubMed ID: 37537025)
1. Incidence and clinical relevance of paraneoplastic syndromes in patients with renal cell carcinoma.
Moldovan T; Boynton D; Kuperus J; Parker J; Noyes SL; Brede CM; Tobert CM; Lane BR
Urol Oncol; 2023 Sep; 41(9):392.e11-392.e17. PubMed ID: 37537025
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.
Moreira DM; Gershman B; Lohse CM; Boorjian SA; Cheville JC; Leibovich BC; Thompson RH
World J Urol; 2016 Oct; 34(10):1465-72. PubMed ID: 26914818
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic syndromes and oncological outcomes in renal cancer.
Ikuerowo SO; Ojewuyi OO; Omisanjo OA; Abolarinwa AA; Bioku MJ; Doherty AF
Niger J Clin Pract; 2019 Sep; 22(9):1271-1275. PubMed ID: 31489865
[TBL] [Abstract][Full Text] [Related]
4. Is there an association between advanced stage of renal cell carcinoma and paraneoplastic syndrome?
Ding GX; Song NH; Feng CC; Xia GW; Jiang HW; Hua LX; Ding Q
Med Princ Pract; 2012; 21(4):370-4. PubMed ID: 22237047
[TBL] [Abstract][Full Text] [Related]
5. Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma.
Hegemann M; Kroeger N; Stenzl A; Bedke J
World J Urol; 2018 Jun; 36(6):849-854. PubMed ID: 29429069
[TBL] [Abstract][Full Text] [Related]
6. Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC).
Cotta BH; Meagher MF; Patil D; Saito K; Patel SH; Patel DN; Miller N; Dutt R; Keiner C; Bradshaw AW; Wan F; Eldefrawy A; Yasuda Y; Fujii Y; Master V; Derweesh IH
BJU Int; 2021 Mar; 127(3):311-317. PubMed ID: 32772468
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system.
Sun R; Breau RH; Mallick R; Tanguay S; Pouliot F; Kapoor A; Lavallée LT; Finelli A; So AI; Rendon RA; Fairey AS; Lattouf JB; Kawakami J; Bhindi B; Basappa NS; Wood LA; Bjarnason GA; Heng DYC; Bansal RK
Can Urol Assoc J; 2021 Apr; 15(4):132-137. PubMed ID: 33007184
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features of urological malignancies with paraneoplastic syndromes].
Yang Y; Mao QZ; Li HZ; Rong S; Yan WG; Ji ZG; Liu GH; Xu WF; Xiao H; Wang HJ
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3411-4. PubMed ID: 21223815
[TBL] [Abstract][Full Text] [Related]
9. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
10. Acute myocardial infarction and arterial embolism in a patient with newly diagnosed renal mass: management dilemmas! A case report.
Martin B; Greinacher A; Bülow R; Hammer F; Hoene A; Burchardt M; Zimmermann U
BMC Urol; 2021 Aug; 21(1):111. PubMed ID: 34407783
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review.
Villagrán-García M; Muñiz-Castrillo S; Ciano-Petersen NL; Vogrig A; Farina A; Villard M; Psimaras D; Alentorn A; Gonçalves D; Fabien N; Rogemond V; Joubert B; Honnorat J
J Neurol; 2023 Jan; 270(1):283-299. PubMed ID: 36050418
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis.
Kim HL; Belldegrun AS; Freitas DG; Bui MH; Han KR; Dorey FJ; Figlin RA
J Urol; 2003 Nov; 170(5):1742-6. PubMed ID: 14532767
[TBL] [Abstract][Full Text] [Related]
13. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic symptoms: cachexia, polycythemia, and hypercalcemia are, respectively, related to vascular endothelial growth factor (VEGF) expression in renal clear cell carcinoma.
Ding GX; Feng CC; Song NH; Fang ZJ; Xia GW; Jiang HW; Hua LX; Ding Q
Urol Oncol; 2013 Nov; 31(8):1820-5. PubMed ID: 22534085
[TBL] [Abstract][Full Text] [Related]
15. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma.
Choi JY; Ko YH; Song PH
Investig Clin Urol; 2016 Sep; 57(5):324-9. PubMed ID: 27617313
[TBL] [Abstract][Full Text] [Related]
17. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis associated with renal cell carcinoma: a paraneoplastic syndrome or just a coincidence.
Zheng Y; Luo J; Jin H; Liu R; Hao H; Gao F
BMC Neurol; 2021 Jul; 21(1):277. PubMed ID: 34253185
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic elevation of serum alkaline phosphatase in renal cell carcinoma: incidence and implication on prognosis.
Chuang YC; Lin AT; Chen KK; Chang YH; Chen MT; Chang LS
J Urol; 1997 Nov; 158(5):1684-7. PubMed ID: 9334578
[TBL] [Abstract][Full Text] [Related]
20. Impact of comorbidity on complications after nephrectomy: use of the Clavien Classification of Surgical Complications.
Hennus PM; Kroeze SG; Bosch JL; Jans JJ
BJU Int; 2012 Sep; 110(5):682-7. PubMed ID: 22432906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
